Advanced Cell Technology Inc. Message Board
-
ACTC target price update on Yahoo Fin
$2.51....I love it
-
It is now N/A
I'd gamble on this if it were below 4 cents. I don't see tax loss selling as being done in early OCT. I could be wrong but the momo here is anything but bullish. The stock, without any revenue and fighting legislation just doesn't rate a buy. Risk is too high, JMO. -
love?
-
Yahoo finance target prices, for penny stocks, are totally meaningless. If you haven't discovered that, by this time, you really are slow.....
-
I think in 3 years we have a shot at that price
- 1 Reply to stemcellsrule16
-
That $2.51 target was there back in late 2004 when I first looked at ACTC. But hey, anything can happen overnight, and on any given night. We've all seen it happen before.
-
Hey raj had to check geron again read bold paragraph 3 paragraph's done it states
Currently there are no sites enrolling patients for this study. The Investigational New Drug application (IND) has been placed on clinical hold by the FDA pending data from a nonclinical animal study being conducted by the company.
Just like to add geron never had sites even when they had approval
http://www.geron.com/patients/clinicaltrials/hESC.aspx -
Its been that way for along while however investors in this stock including myself would love it but i don't see it yet lets see what happens with the pp's after FDA approval of IND
- 1 Reply to jonnyrocket419
-
Thanks. I think once trials resume we will see PPS movement.
-